Journal of the American Society of Hypertension
Volume 2, Issue 6 , Pages 439-447, November 2008

Murine and rat cavernosal responses to endothelin-1 and urotensin-II Vasoactive Peptide Symposium

  • Fernando S. Carneiro, MSc

      Affiliations

    • Medical College of Georgia, Department of Physiology, Augusta, Georgia, USA
    • Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil
    • Corresponding Author InformationCorresponding author: Fernando S. Carneiro, MSc, Medical College of Georgia, Department of Physiology, 1120 15th Street, CA-3141, Augusta, Georgia 30912. Tel: 706-721-0784; fax: 706-721-7299
  • ,
  • Zidonia N. Carneiro

      Affiliations

    • Medical College of Georgia, Department of Physiology, Augusta, Georgia, USA
  • ,
  • Fernanda R.C. Giachini, MSc

      Affiliations

    • Medical College of Georgia, Department of Physiology, Augusta, Georgia, USA
    • Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil
  • ,
  • Victor V. Lima, BSc

      Affiliations

    • Medical College of Georgia, Department of Physiology, Augusta, Georgia, USA
  • ,
  • Edson F. Nogueira, MD

      Affiliations

    • Medical College of Georgia, Department of Physiology, Augusta, Georgia, USA
  • ,
  • William E. Rainey, PhD

      Affiliations

    • Medical College of Georgia, Department of Physiology, Augusta, Georgia, USA
  • ,
  • Rita C. Tostes, PhD

      Affiliations

    • Medical College of Georgia, Department of Physiology, Augusta, Georgia, USA
    • Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil
  • ,
  • R. Clinton Webb, PhD

      Affiliations

    • Medical College of Georgia, Department of Physiology, Augusta, Georgia, USA

Received 5 March 2008; accepted 8 July 2008. published online 15 September 2008.

Abstract 

Endothelin-1 (ET-1) and urotensin-II (U-II) are the most potent constrictors of human vessels. Although the cavernosal tissue is highly responsive to ET-1, no information exists on the effects of U-II on cavernosal function. The aim of this study was to characterize ET-1 and U-II responses in corpora cavernosa from rats and mice. Male Wistar rats and C57/BL6 mice were used at 13 weeks. Cumulative concentration-response curves to ET-1, U-II, and IRL-1620, an ETB agonist, were performed. ET-1 increased force generation in cavernosal strips from mice and rats, but no response to U-II was observed in the presence or absence of Nω-nitro-L-arginine methyl ester (L-NAME), or in strips prestimulated with 20 mM KCl. IRL-1620 did not induce cavernosal contraction even in presence of L-NAME, but induced a cavernosal relaxation that was greater in rats than mice. No relaxation responses to U-II were observed in cavernosal strips precontracted with phenylephrine. mRNA expression of ET-1, ETA, ETB, and U-II receptors, but not U-II was observed in cavernosal strips. ET-1, via ETA receptors activation, causes contractile responses in cavernosal strips from rats and mice, whereas ETB receptor activation produces relaxation. Although the cavernosal tissue expresses U-II receptors, U-II does not induce contractile responses in corpora cavernosa from mice or rats.

Keywords: ETA receptor, DOCA-salt hypertension, erectile dysfunction, corpus cavernosum

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 This study was supported by Grants from the National Institutes of Health (HL71138 and HL74167), Bethesda, Maryland and Fundacao de Amparo a Pesquisa do Estado de São Paulo, FAPESP, Brazil.

PII: S1933-1711(08)00144-7

doi:10.1016/j.jash.2008.07.001

Journal of the American Society of Hypertension
Volume 2, Issue 6 , Pages 439-447, November 2008